tiprankstipranks
Aura Biosciences Inc (AURA)
NASDAQ:AURA
US Market

Aura Biosciences Inc (AURA) Financial Statements

78 Followers

Aura Biosciences Inc Financial Overview

Aura Biosciences Inc's market cap is currently ―. The company's EPS TTM is $-1.928; its P/E ratio is -3.65; Aura Biosciences Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.99M$ -18.51M$ -18.30M$ -17.47M$ 25.64M
EBITDA$ -21.67M-$ -18.00M$ -17.14M$ 25.97M
Net Income Common Stockholders$ -22.13M$ -18.51M$ -18.30M$ -17.47M$ 25.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 226.15M$ 149.06M$ 162.03M$ 173.54M$ 188.83M
Total Assets$ 255.07M$ 179.77M$ 192.74M$ 206.02M$ 223.94M
Total Debt$ 19.56M$ 20.19M$ 20.41M$ 20.64M$ 20.86M
Net Debt$ -206.59M$ -128.87M$ -141.62M$ -152.90M$ -167.97M
Total Liabilities$ 29.23M$ 28.05M$ 26.30M$ 25.76M$ 28.35M
Stockholders Equity$ 225.85M$ 151.72M$ 166.44M$ 180.26M$ 195.58M
Cash Flow-
Free Cash Flow$ -17.70M-$ -14.84M$ -16.52M$ -18.37M
Operating Cash Flow$ -17.39M$ -15.40M$ -14.64M$ -16.41M$ -18.01M
Investing Cash Flow$ -90.12M$ 21.63M$ 21.41M$ -66.88M$ -16.88M
Financing Cash Flow$ 92.98M$ 1.63M$ 2.48M$ 201.00K$ 95.20M
Currency in USD

Aura Biosciences Inc Earnings and Revenue History

Aura Biosciences Inc Debt to Assets

Aura Biosciences Inc Cash Flow

Aura Biosciences Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis